Annual | 12/2023FY | 12/2024FY |
---|---|---|
Total Revenue | $28.54 B | $34.12 B |
Net Income | $6.24 B | $5.24 B |
Quarterly | 9/30/2023 | 12/31/2023 |
Total Assets | $57.92 B | $64.01 B |
Total Liabilities | $53.14 B | $51.05 B |
Operating Margin | 36.06% | 32.91% |
Eli Lilly & Co.
Lilly Corporate Center |
|
Industry | Pharmaceuticals: Major |
---|---|
Sector | Health Technology |
Employees | 43,000 |
Mr. David A. Ricks | Ms. Ruth Gimeno | Mr. David A. Ricks | ||||||||||||||||||||||||||
Chairman, President & Chief Executive Officer | Vice President | Chairman, President & Chief Executive Officer | ||||||||||||||||||||||||||
Mr. Gordon Brooks | Dr. David Hyman | Mr. Diogo Rau | Dr. Daniel M. Skovronsky | Mr. Ralph Alvarez | Mr. Ralph Alvarez | Dr. Katherine Baicker | Dr. Katherine Baicker | Ms. Gabrielle G. Greene-Sulzberger | Mr. David A. Ricks | Mr. Jon Erik Fyrwald | Mr. Jon Erik Fyrwald | Dr. William G. Kaelin | Dr. William G. Kaelin | Dr. Marschall S. Runge | Dr. Marschall S. Runge | Mr. Juan Ricardo Luciano | Mr. Juan Ricardo Luciano | Mr. Jamere Jackson | Mr. Jamere Jackson | Ms. Gabrielle G. Greene-Sulzberger | Ms. Kimberly H. Johnson | Dr. Mary Lynne Hedley | Dr. Mary Lynne Hedley | Ms. Kimberly H. Johnson | Ms. Karen Walker | Ms. Karen Walker | Ms. Anat Hakim | |
Chief Financial Officer | Chief Medical Officer | Executive VP, Chief Information & Digital Officer | Chief Scientific Officer & Executive VP | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Chairman, President & Chief Executive Officer | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Lead Independent Director | Lead Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Secretary, Executive VP & General Counsel |
Company Name | Price | EPS (FY) | Annual Dividend | Book Value (FY) | Cash Flow (FY) |
---|---|---|---|---|---|
Eli Lilly & Co. | $804.62 | 6.69 | 4.52 | 13.48 | 9.10 |